CorMedix closes $150M convertible note offering due 2030 at 4.00% interest

CorMedix Inc.

Issued $150M aggregate principal of 4.00% Convertible Senior Notes due 2030 in a private placement.
Initial conversion rate: 74.2515 shares per $1,000 principal (implied conversion price ~$13.47/share).
Notes issued under indenture with U.S. Bank Trust Company; proceeds not specified but likely for corporate purposes.
Sale exempt from registration under Section 4(a)(2) of the Securities Act.

item 1.01item 3.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.